Barclays
INGN icon

Barclays’s Inogen INGN Stock Holding History

Barclays’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,000
Closed -$95K – 7078
2019
Q1 		$95K Sell
1,000
-10,000
-91% -$1.25M ﹤0.01% 5397
2018
Q4 		$1.37M Buy
+11,000
New +$1.81M ﹤0.01% 2797

Other funds holding INGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays's INGN Position: Q1 2026 in Review

Barclays reduced its Inogen (INGN) stake by 47% in Q1 2026, selling an estimated $240K and leaving 43,087 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #3531.

Barclays first reported a position in INGN in Q1 2014 and has held it in 49 quarters since. The position peaked at $3.79M in Q4 2015. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • Barclays held 43,087 shares of Inogen worth $266K as of Q1 2026.
  • Barclays sold 38,893 Inogen shares in Q1 2026, an estimated $240K.
  • Inogen made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3531 holding.
  • Barclays first reported a position in Inogen in Q1 2014 and has held it in 49 quarters since.
  • Barclays's Inogen position peaked at $3.79M in Q4 2015.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.